Cargando…
Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials
Cord blood (CB) provides an excellent alternative source of hematopoietic progenitor cells (HPC) for patients lacking human leukocyte antigen-matched peripheral blood or bone marrow graft for transplantation. However, due to the limited cell dose in CB graft, it is associated with prolonged time to...
Autores principales: | Mehta, Rohtesh S., Rezvani, Katayoun, Olson, Amanda, Oran, Betul, Hosing, Chitra, Shah, Nina, Parmar, Simrit, Armitage, Sue, Shpall, Elizabeth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675847/ https://www.ncbi.nlm.nih.gov/pubmed/26697430 http://dx.doi.org/10.3389/fmed.2015.00089 |
Ejemplares similares
-
Cord Blood as a Source of Natural Killer Cells
por: Mehta, Rohtesh S., et al.
Publicado: (2016) -
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation
por: Cao, Kai, et al.
Publicado: (2018) -
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
por: Mehta, Rohtesh S., et al.
Publicado: (2018) -
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation
por: Andersson, Borje S., et al.
Publicado: (2022) -
Ex vivo generation of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigen
por: Kellner, Joshua N., et al.
Publicado: (2018)